-The Telegraph Ranchi: The Aadhaar-enabled public distribution system (PDS) launched in Ranchi on pilot basis threw up a tragic loophole today when around 50 leprosy Patients turned up at their ward councillor's office, saying they had not received ration for the past three months as they lacked thumbs and fingers to verify their biometric identity. The 50-odd leprosy Patients, including women, told ward 43 councillor Chanda Devi their very survival was at...

-The Hindu MSF Secretary General Jerome Oberreit on the increasing threat to affordable health care worldwide. Médecins Sans Frontières (MSF) or Doctors without Borders, the international humanitarian medical aid organisation that is active in 69 countries, serves populations affected by epidemics, armed conflicts, natural calamities and manmade disasters. MSF has relied heavily on generic drugs, much of which has been sourced from India, to deliver health care to some of the most...

-The Hindu Chief medical officers of 72 districts colluded with politicians and contractors in swindling funds meant for poor Patients; the CBI has filed 82 cases so far Investigations into the Rs. 9,000-crore National Rural Health Mission (NRHM) scam in Uttar Pradesh have led to the arrest of 149 persons, with the Central Bureau of Investigation arraigning 350 people as accused in 82 cases of corruption, cheating, forgery and conspiracy registered so...

-Hindustan Times India’s generic drug manufacturers have flooded the market with cheaper medicines to treat hepatitis C after Gilead Sciences Inc’s patent application was rejected in January 2015. Thanks to domestic drugmakers, the world is looking to India to reduce the price of hepatitis C drug further. “By scaling up the production of generic medicines, India is playing a pivotal role globally in reducing the prices of medicines for hepatitis C,” said Henk...

-The Times of India LUCKNOW: Seeing their child in tears each time an insulin pen pricks the belly isn't the only pain parents of a type-1 diabetic child have to go through. The cost associated with management of the disease hurts equally, if not more. A middle-income family spends an estimated 18% of family income on the disease. The findings are from a study conducted by the department of endocrinology at Sanjay...